Correcting AHR signaling via administration of AHR agonist FICZ or transplantation of Trp-metabolizing Lactobacillus strains proved to be effective at reducing intestinal inflammation in a mouse model of inflammatory bowel disease (49), and FICZ also attenuated skin inflammation in a mouse model of psoriasis (50). Here, AHR is linked to gastroenteritis.